Koutras A, Zagouri F, Koliou GA, Psoma E, et al. Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial. Br J Cancer 2020 Jun 3. pii: 10.1038/s41416-020-0909.
PMID: 32488135